Inventor · disambiguated record
Viktoria Kheifets
Also filed as: KHEIFETS VIKTORIA
15 granted patents·17 pending applications·128 citations·filing 2005–2024
92Inventor score
Files withALKAHEST INC12EDISON PHARMACEUTICALS INC6MILLER GUY M5BIOELECTRON TECH CORP4PTC THERAPEUTICS INC2
Top patents by PatentIndex Score
32 records- 0198US8653144B2Treatment of pervasive developmental disorders with redox-active therapeuticsEDISON PHARMACEUTICALS INC·Filed 2012·Granted Feb 18, 2014·32 cites·31 claims
- 0296US8314153B2Treatment of pervasive developmental disorders with redox-active therapeuticsMILLER GUY M·Filed 2009·Granted Nov 20, 2012·51 cites·24 claims
- 0392US11298377B2Methods of improving wound healingALKAHEST INC·Filed 2019·Granted Apr 12, 2022·4 cites·18 claims
- 0492US11103530B2Methods of improving or accelerating postoperative recoveryALKAHEST INC·Filed 2019·Granted Aug 31, 2021·7 cites·5 claims
- 0592US10105325B2Treatment of pervasive developmental disorders with redox-active therapeuticsBIOELECTRON TECH CORP·Filed 2016·Granted Oct 23, 2018·4 cites·20 claims
- 0691US11484551B2Method of treating liver failure with plasma fraction IV-4ALKAHEST INC·Filed 2021·Granted Nov 1, 2022·2 cites·15 claims
- 0791US11439687B2Blood plasma fractions for use in muscle regenerationALKAHEST INC·Filed 2020·Granted Sep 13, 2022·3 cites·8 claims
- 0890US8969420B2Treatment of pervasive developmental disorders with redox-active therapeuticsEDISON PHARMACEUTICALS INC·Filed 2014·Granted Mar 3, 2015·9 cites·22 claims
- 0985US10470986B2Resorcinol compounds for dermatological useCONOPCO INC·Filed 2014·Granted Nov 12, 2019·10 cites·5 claims
- 1084US11547724B2Methods of treating a subject for painALKAHEST INC·Filed 2020·Granted Jan 10, 2023·1 cites·8 claims
- 1182US9629815B2Benzoquinone derivatives for treating oxidative stress disordersEDISON PHARMACEUTICALS INC·Filed 2013·Granted Apr 25, 2017·5 cites·17 claims
- 1279US2023285455A1Use of Plasma and Plasma Fractions for Improvement of Pain, Wound Healing, and Postoperative RecoveryALKAHEST INC·Filed 2023·Application pending·0 cites
- 1378US12053489B2Blood plasma fractions for use in liver regenerationALKAHEST INC·Filed 2022·Granted Aug 6, 2024·0 cites·12 claims
- 1477US2024342212A1Blood Plasma Fractions for Use in Liver RegenerationALKAHEST INC·Filed 2024·Application pending·0 cites
- 1577US2023111752A1Use of Plasma and Plasma Fractions for Improvement of Pain, Wound Healing, and Postoperative RecoveryALKAHEST INC·Filed 2022·Application pending·0 cites
- 1675US10736857B2Treatment of pervasive developmental disorders with redox-active therapeuticsPTC THERAPEUTICS INC·Filed 2018·Granted Aug 11, 2020·0 cites·20 claims
- 1774US12059453B2Blood plasma fractions for use in muscle regenerationALKAHEST INC·Filed 2022·Granted Aug 13, 2024·0 cites·9 claims
- 1874US2024358802A1Blood Plasma Fractions for Use in Muscle RegenerationALKAHEST INC·Filed 2024·Application pending·0 cites
- 1974US2021128494A1Treatment of pervasive developmental disorders with redox-active therapeuticsPTC THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2061US11660316B2Methods of inducing liver regeneration by administering a plasma protein fractionALKAHEST INC·Filed 2020·Granted May 30, 2023·0 cites·8 claims
- 2156US2018344667A1Methods for the prevention and treatment of cerebral ischemiaBIOELECTRON TECH CORP·Filed 2018·Application pending·0 cites
- 2255US2018116978A1Formulations of tocotrienol quinones for the treatment of ophthalmic diseasesBIOELECTRON TECH CORP·Filed 2017·Application pending·0 cites
- 2355US2014031433A1Formulations of tocotrienol quinones for the treatment of ophthalmic diseasesEDISON PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2451US2009291092A1Treatment of mitochondrial diseases with an erythropoietin mimeticMILLER GUY M·Filed 2009·Application pending·0 cites
- 2549US2017007553A1Methods for the prevention and treatment of cerebral ischemiaEDISON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2649US2011207828A1Methods for the prevention and treatment of cerebral ischemiaMILLER GUY M·Filed 2010·Application pending·0 cites
- 2748US2010273892A1Formulations of tocotrienol quinones for the treatment of ophthalmic diseasesMILLER GUY M·Filed 2010·Application pending·0 cites
- 2848US2009081786A1Peptide sequences for modulation of protein kinase CKHEIFETS VIKTORIA·Filed 2007·Application pending·0 cites
- 2947US2017209393A1Benzoquinone derivatives for treating oxidative stress disordersBIOELECTRON TECH CORP·Filed 2017·Application pending·0 cites
- 3045US2016115141A1Carboxylic acid derivatives for treatment of oxidative stress disordersEDISON PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3136US2012136048A1Topical, periocular, or intraocular use of tocotrienols for the treatment of ophthalmic diseasesMILLER GUY M·Filed 2010·Application pending·0 cites
- 3236US2009155236A1Peptide sequence for modulation of delta protein kinase cNAT INSTITUES OF HEALTH NIH U·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →